Cargando…
Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents
BACKGROUND: Developments in cell-based and gene-based therapies are emerging as highly promising areas to complement pharmaceuticals, but present day approaches are too cumbersome and thereby limit their clinical usefulness. These shortcomings result in procedures that are too complex and too costly...
Autores principales: | Mosca, Joseph D, Chang, Yung-Nien, Williams, Gregory |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885814/ https://www.ncbi.nlm.nih.gov/pubmed/17504532 http://dx.doi.org/10.1186/1742-4690-4-32 |
Ejemplares similares
-
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
por: Kampf, G., et al.
Publicado: (2020) -
Structured particles for antigen presentation
por: Buonaguro, L, et al.
Publicado: (2006) -
Activation and degranulation of CAR-T cells using engineered antigen-presenting cell surfaces
por: Dirar, Qassim, et al.
Publicado: (2020) -
Particle Engineering in Pharmaceutical Solids Processing: Surface Energy
Considerations
por: Williams, Daryl R.
Publicado: (2015) -
Particle technology and engineering: an engineer's guide to particles and powders : fundamentals and computational approaches
por: Seville, J P K, et al.
Publicado: (2016)